Aspirin and Extended-Release Dipyridamole (AvKARE, Inc.)
Welcome to the PulseAid listing for the Aspirin and Extended-Release Dipyridamole drug offered from AvKARE, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
| NON-PROPRIETARY NAME: | Aspirin and Extended-Release Dipyridamole |
| SUBSTANCE NAME: | ASPIRIN; DIPYRIDAMOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-27 |
| END MARKETING DATE: | 0000-00-00 |
Aspirin and Extended-Release Dipyridamole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aspirin and Extended-Release Dipyridamole from AvKARE, Inc. |
| LABELER NAME: | AvKARE, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 200(mg/1; mg/1) |
| START MARKETING DATE: | 2017-04-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42291-116_01ed3ebb-ea0f-416a-990e-2a81cb9e2257 |
| PRODUCT NDC: | 42291-116 |
| APPLICATION NUMBER: | ANDA206392 |
Other ASPIRIN; DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:
